Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

Norbert Galldiks; Marion Rapp; Gabriele Stoffels; Gereon Rudold Fink; Nadim Joni Shah; Heinz Hubert Coenen; Michael Christoph Sabel; Karl-Josef Langen

doi:10.1007/s00259-012-2251-4

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

Norbert Galldiks, Marion Rapp, Gabriele Stoffels, Gereon Rudold Fink, Nadim Joni Shah, Heinz Hubert Coenen, Michael Christoph Sabel, Karl-Josef Langen

Research output: Contribution to journal › Article › Research › peer-review

154 Citations (Scopus)

Original language	English
Pages (from-to)	22 - 33
Number of pages	12
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	40
Issue number	1
DOIs	https://doi.org/10.1007/s00259-012-2251-4
Publication status	Published - 2013
Externally published	Yes

Access to Document

10.1007/s00259-012-2251-4

Cite this

Galldiks, N., Rapp, M., Stoffels, G., Fink, G. R., Shah, N. J., Coenen, H. H., Sabel, M. C., & Langen, K.-J. (2013). Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI. European Journal of Nuclear Medicine and Molecular Imaging, 40(1), 22 - 33. https://doi.org/10.1007/s00259-012-2251-4

@article{34a833375173487e83e021ed3008bdfd,

title = "Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI",

author = "Norbert Galldiks and Marion Rapp and Gabriele Stoffels and Fink, {Gereon Rudold} and Shah, {Nadim Joni} and Coenen, {Heinz Hubert} and Sabel, {Michael Christoph} and Karl-Josef Langen",

year = "2013",

doi = "10.1007/s00259-012-2251-4",

language = "English",

volume = "40",

pages = "22 -- 33",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "1",

}

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI. / Galldiks, Norbert; Rapp, Marion; Stoffels, Gabriele et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, No. 1, 2013, p. 22 - 33.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

AU - Galldiks, Norbert

AU - Rapp, Marion

AU - Stoffels, Gabriele

AU - Fink, Gereon Rudold

AU - Shah, Nadim Joni

AU - Coenen, Heinz Hubert

AU - Sabel, Michael Christoph

AU - Langen, Karl-Josef

PY - 2013

Y1 - 2013

UR - http://search.proquest.com.ezproxy.lib.monash.edu.au/docview/1266427500?accountid=12528

U2 - 10.1007/s00259-012-2251-4

DO - 10.1007/s00259-012-2251-4

M3 - Article

SN - 1619-7070

VL - 40

SP - 22

EP - 33

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 1

ER -

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

Access to Document

Other files and links

Cite this